Study
|
Name
|
Status
|
Phase
|
| 0011 |
Phase III Randomized Study of Adjuvant Therapy for High Risk pT2-3N0 Prostate Cancer |
Terminated |
III |
| 0012 |
Randomized Phase II Trial of Preoperative Combined Modality Chemoradiation for Distal Rectal Cancer |
Terminated |
II |
| 0013 |
A Phase II Trial of Conventional Radiation Therapy followed by Intratumoral Bleomycin Delivered using a Refillable Sustained Device (IND#46,592) for the Treatment of Supratentorial Glioblastoma |
Terminated |
II |
| 0014 |
A Phase III Randomized Study of Patients with High Risk, Hormone-Naive Prostate Cancer: Androgen Blockade with 4 Cycles of Immediate Chemotherapy versus Androgen Blockade with Delayed Chemotherapy |
Terminated |
III |
| 0015 |
SWOG 9900/Endorsed Study: A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer (NSCLC) |
Terminated |
III |
| 0017 |
A Phase I Study of Gemcitabine, Carboplatin or Gemcitabine, Paclitaxel and Radiation Therapy for Patients with Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) |
Terminated |
I |
| 0018 |
A Feasibility Study of Neurocognitive Evaluation in Patients Treated for Brain Metastases |
Terminated |
I |
| 0019 |
A Phase II Study of External Beam Radiation Therapy Combined with Permanent Source Brachytherapy for Intermediate Risk Clinically Localized Adenocarcinoma of the Prostate |
Terminated |
II |
| 0020 |
A Randomized Phase II Trial of Weekly Gemcitabine, Paclitaxel and External Irradiation (50.4 Gy) Followed by the Farnesyl Transferase Inhibitor R115777 (NSC #702818) for Locally Advanced Pancreatic Cancer |
Terminated |
II |
| 0021 |
A Phase II Trial of Conventional Radiation Therapy plus High Dose Tamoxifen for the Treatment of Supratentorial Glioblastoma Multiforme (GBM) |
Terminated |
II |
| 0022 |
Phase I/II Study of Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer |
Terminated |
I/II |
| 0023 |
A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts for Supratentorial Glioblastoma Multiforme |
Terminated |
II |
| 0024 |
Phase II Trial of Early Postoperative Paclitaxel Followed By Paclitaxel and Cisplatin Concurrent With Radiation Therapy for Resected, High-Risk Squamous Carcinoma of the Head and Neck |
Terminated |
II |
| 0113 |
Non-operative Therapy of Local Regional Carcinoma of the Esophagus: A Randomized Phase II Study of Two Paclitaxel-Based Chemoradiotherapy Regimens |
Terminated |
II |
| 0114 |
Randomized Phase II Comparison of Two Cisplatin-Paclitaxel Containing Chemoradiation Regimens in Resected Gastric Cancers |
Terminated |
II |
| 0116 |
A Two Part Phase I/II Study of Extended Field External Irradiation and Intracavitary Brachytherapy Combined with Chemotherapy and Amifostine in Carcinoma of the Cervix with Positive Para-Aortic or High Common Iliac Lymph Nodes |
Terminated |
I/II |
| 0117 |
A Phase I/II Dose Intensification Study Using Three Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients with Inoperable, Non-Small Cell Lung Cancer |
Terminated |
I/II |
| 0118 |
A Phase III Study of Conventional Radiation Therapy Plus Thalidomide (Nsc# 66847) Versus Conventional Radiation Therapy for Multiple Brain Metastases |
Terminated |
III |
| 0119 |
A Randomized Phase II Study of A.M. And P.M. Melatonin for Brain Metastasis in RPA Class II Patients |
Terminated |
II |
| 0120 |
A Randomized Phase I/II Study of Preoperative Radiotherapy With/Without Sugen 5416 (NSC #696819; A TK Inhibitor Anti-Angiogenesis Compound) in the Management of Low to Intermediate Grade Soft Tissue Sarcoma of the Trunk or Extremity |
Terminated |
I/II |
| 0121 |
A Phase I/II Study of Neoadjuvant Chemotherapy, Angiogenesis Inhibitor SU5416 (NSC #696819; A TK Inhibitor Anti-Angiogenesis Compound), and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall |
Terminated |
I/II |
| 0122 |
A Double-Blind Study of Nutritional Intervention for the Treatment of Cancer Cachexia Using Juven® Nutritional Supplement |
Terminated |
I |
| 0123 |
A Phase II Randomized Trial With Captopril in Patients Who Have Received Radiation Therapy +/ Chemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer or Limited Stage Small Cell Lung Cancer---RTOG CCOP Study |
Terminated |
II |
| 0124 |
A Phase II Study of Multimodality Therapy for Primary and Recurrent Retroperitoneal Sarcomas |
Terminated |
II |
| 0128 |
A Phase I/II Study of Cox-2 Inhibitor, Celebrex™ (Celecoxib) And Chemo-Radiation In Patients With Locally Advanced Cervical Cancer |
Terminated |
I/II |
| 0132 |
A Phase II Trial of Neoadjuvant/Adjuvant STI-571 (Gleevec NSC #716051) for Primary and Recurrent Operable Malignant GIST Expressing the Kit Receptor Tyrosine Kinase (CD117) |
Terminated |
II |
| 0211 |
A Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor (EGFR-TKI), ZD 1839 (IRESSA) [NSC# 715055] with Radiation Therapy in Glioblastoma Multiforme |
Terminated |
I/II |
| 0212 |
A Phase II/III Randomized Trial of Two Dose Schedules for Delivering Prophylactic Cranial Irradiation for Patients with Limited Disease Small Cell Lung Cancer (Companion Study to the International Cranial Irradiation Trial, PCI 01EULINT1) |
Terminated |
II/III |
| 0213 |
A Phase I/II Trial of a Cox2 Inhibitor, Celebrex™ (Celecoib), [NSC# 719627] with Limited Field Radiation for Intermediate Prognosis Patients with Locally Advanced Non-Small Cell Lung Cancer, with Analysis of Prognostic Factors |
Terminated |
I/II |
| 0214 |
A Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer |
Terminated |
III |
| 0215 |
Treatment of Erectile Dysfunction in Patients Treated on RTOG 9910 for Prostate Cancer: Impact on Patient and Partner Quality of Life---RTOG CCOP Study |
Terminated |
III |
| 0225 |
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) +/ Chemotherapy for Nasopharyngeal Cancer |
Terminated |
II |
| 0227 |
Phase I/II Study of Pre-Irradiation Chemotherapy with Methotrexate, Rituximab, and Temozolomide and Post-Irradiation Temozolomide for Primary Central Nervous System Lymphoma |
Terminated |
I/II |
| 0229 |
A Phase II Trial of Neoadjuvant Therapy with Concurrent Chemotherapy and High Dose Radiotherapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-Small Cell Lung Carcinoma |
Terminated |
II |
| 0234 |
A Phase II Randomized Trial of Surgery Followed by Chemoradiotherapy Plus C225 (Cetuximab) for Advanced Squamous Cell Carcinoma of the Head and Neck |
Terminated |
II |
| 0235 |
ACRIN 6668: Positron Emission Tomography Pre- and Post-Treatment Assessment for Locally Advanced Non-Small Cell Lung Carcinoma |
Terminated |
I |
| 0236 |
A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer |
Terminated |
II |
| 0239 |
A Phase II Study of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy for Patients With Limited Small Cell Lung Cancer |
Terminated |
II |
| 0241 |
Phase I Study of Irinotecan and Cisplatin in Combination With Twice Daily Thoracic Radiotherapy (45 Gy) or Once Daily Thoracic Radiotherapy (70 Gy) For Patients With Limited Stage Small Cell Lung Cancer |
Terminated |
I |
| 0244 |
A Phase II Study of Submandibular Salivary Gland Transfer to the Submental Space Prior to Start of Radiation Treatment for Prevention of Radiation-Induced Xerostomia in Head and Neck Cancer Patients |
Terminated |
II |
| 0246 |
A Phase II Study of a Paclitaxel-Based Chemoradiotherapy Regimen with Selective Surgical Salvage for Resectable Loco-Regionally Advanced Carcinoma of the Esophagus |
Terminated |
II |
| 0247 |
Randomized Phase II Trial of Neoadjuvant Combined Modality Therapy for Locally Advanced Rectal Cancer |
Terminated |
II |
| 0275 |
NCIC CTG BR.19/Endorsed Study:"A Phase III Prospective Randomized, Double-Blind, Placebo-Controlled Trial of the Epidermal Growth Factor Receptor Anatagonist ZD 1839 (IRESSA) in Completely Resected Stage IB, II, and IIIA Non-Small Cell Lung Cancer" |
Terminated |
III |
| 0315 |
A Randomized, Double Blind, Placebo-Controlled Phase III Study to Determine the Efficacy of Sandostatin LAR® Depot (Octreotide Acetate) in Preventing or Reducing the Severity of Chemoradiation-Induced Diarrhea in Patients With Anal or Rectal Cancer---RTOG CCOP Study |
Terminated |
III |
| 0319 |
A Phase I/II Trial to Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity For Stage I And II Breast Carcinoma |
Terminated |
I/II |
| 0320 |
A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases |
Terminated |
III |
| 0321 |
Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate |
Terminated |
II |
| 0324 |
A Phase II Study of Cetuximab (C225) In Combination with Chemoradiation in Patients with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) |
Terminated |
II |
| 0330 |
A Pilot Phase II Study of Preoperative Radiation Therapy and Thalidomide (IND 48832; NSC 66847) for Low Grade Primary Soft Tissue Sarcoma or Preoperative MAID/Thalidomide/Radiation Therapy for High/Intermediate Grade Primary Soft Tissue Sarcoma of the Extremity or Body Wall |
Terminated |
II |
| 0411 |
A Phase II Study of Bevacizumab with Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer |
Terminated |
II |
| 0412 |
Phase III Randomized Trial of Preoperative Chemotherapy Versus Preoperative Concurrent Chemotherapy and Thoracic Radiotherapy Followed by Surgical Resection and Consolidation Chemotherapy in Favorable Prognosis Patients with Stage IIIa (N2) Non-Small Cell |
Terminated |
III |
| 0417 |
A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma |
Terminated |
II |
| 0418 |
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis +/ Chemotherapy for Postoperative Patients with either Endometrial or Cervical Carcinoma |
Terminated |
II |
| 0420 |
Phase II Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide Plus Irinotecan for Glioblastoma Multiforme |
Terminated |
II |
| 0421 |
A Phase III Trial for Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent ReIrradiation and Chemotherapy Versus Chemotherapy Alone |
Terminated |
III |
| 0433 |
NCIC CTG SC.20: A Phase III International Randomized Trial of Single versus Multiple Fractions for Re-Irradiation of Painful Bone Metastases---CCOP Study |
Terminated |
III |
| 0435 |
A Randomized, Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin (NSC# 740548) for the Reduction of Oral Mucositis in Patients with Locally Advanced Head and Neck Cancer Receiving Radiation Therapy with Con |
Terminated |
I |
| 0438 |
Phase I Trial of Highly Conformal Radiation Therapy for Patients with Liver Metastases |
Terminated |
I |
| 0514 |
Establishment of a Head and Neck Cancer Tissue/Specimen Repository |
Terminated |
CS |
| 0515 |
A Comparative Study of Gross Tumor Volume Definition With or Without PET Fusion for Patients with Non-Small Cell Lung Carcinoma |
Terminated |
I |
| 0517 |
A Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases From Lung, Breast, and Prostate Cancer---RTOG CCOP Study |
Terminated |
III |
| 0518 |
A Phase III Randomized Trial to Evaluate the Efficacy of Zometa® for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for High-Grade and/or Locally Advanced Prostate Cancer---RTOG CCOP Study |
Terminated |
III |
| 0525 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma |
Terminated |
III |
| 0529 |
A Phase II Evaluation of Dose-Painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal Canal |
Terminated |
II |
| 0571 |
CALGB 80101/Endorsed Study: A Phase III Intergroup Trial of Adjuvant Chemoradiation after Resection of Gastric or Gastroesophageal Adenocarcinoma |
Terminated |
III |
| 0572 |
SWOG S0424/Endorsed Study: “Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men" |
Terminated |
CS |
| 0611 |
Urinary VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence |
Terminated |
CS |
| 0612 |
Investigating Markers of Radiation Outcome in Patients with Intermediate-Risk Prostate Cancer Using DNA Microarray Analysis: An RTOG Pilot Study |
Terminated |
CS |
| 0614 |
A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy---RTOG CCOP Study |
Terminated |
III |
| 0619 |
A Randomized Phase II Trial of Chemoradiotherapy Versus Chemoradiotherapy and Vandetanib For High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck |
Terminated |
II |
| 0622 |
A Phase II Trial of Samarium 153 Followed By Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation In High-Risk, Clinically Non-Metastatic Prostate Cancer after Radical Prostatectomy |
Terminated |
II |
| 0623 |
A Phase II Trial of Combined Modality Therapy with Growth Factor Support for Patients with Limited Stage Small Cell Lung Cancer |
Terminated |
II |
| 0625 |
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma |
Terminated |
II |
| 0671 |
NCCTG 0574/Endorsed Study: Phase III Randomized Trial of Whole Brain Radiation in Addition to Radiosurgery in Patients with One to Three Cerebral Metastases |
Terminated |
III |
| 0674 |
CALGB 90202/Endorsed Study: "A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men With Prostate Cancer Metastatic to Bone" |
Terminated |
III |
| 0822 |
A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination with Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer |
Terminated |
II |
| 0825 |
Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma |
Terminated |
III |
| 0831 |
A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer---RTOG CCOP Study |
Terminated |
III |
| 0841 |
Efficiency of Screening for Depression in Cancer Patients Receiving Radiotherapy---RTOG CCOP Study |
Terminated |
I |
| 0870 |
CALGB 140503/Endorsed Study: "A Phase III Randomized Trial Of Lobectomy Versus Sublobar Resection For Small (< 2 Cm) Peripheral Non-Small Cell Lung Cancer" |
Terminated |
III |
| 0873 |
NCIC CTG PR.11/Endorsed Study: "A Phase III Study Of Active Surveillance Therapy Against Radical Treatment In Patients Diagnosed With Favourable Risk Prostate Cancer (START)" |
Terminated |
III |
| 0921 |
A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) With Concurrent Cisplatin and Bevacizumab Followed By Carboplatin and Paclitaxel For Patients with Endometrial Cancer |
Terminated |
II |
| 0925 |
Natural History of Postoperative Cognitive Function, Quality of Life, and Seizure Control in Patients With Supratentorial Low-Risk Grade II Glioma |
Terminated |
III |
| 0929 |
A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma |
Terminated |
I/II |
| 0933 |
A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases--RTOG CCOP Study |
Terminated |
II |
| 0937 |
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone To Prophylactic Cranial Irradiation And Consolidative Extra-Cranial Irradiation For Extensive Disease Small Cell Lung Cancer (ED-SCLC) |
Terminated |
II |
| 0971 |
SWOG S0809/Endorsed Study: "A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)" |
Terminated |
II |
| 0972 |
CALGB 30605/Endorsed Study: "A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung Cancer" |
Terminated |
II |
| 1012 |
Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer - RTOG CCOP Study (open to U.S. sites only) |
Terminated |
II R |
| 1021 |
A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) |
Terminated |
III |
| 1070 |
GOG-0249/Endorsed Study: "A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma" |
Terminated |
III |
| 1102 |
A Phase I Study of Induction Ganitumab (IND #113278) and Gemcitabine, Followed by Ganitumab, Capecitabine, and 3D-Conformal Radiation Therapy (3D-CRT) With Subsequent Maintenance Therapy for Locally Advanced Pancreatic Cancer |
Terminated |
I |
| 1201 |
A Phase II Randomized Trial of High Versus Standard Intensity Local or Systemic Therapy for Unresectable Pancreatic Cancer |
Terminated |
II R |
| 1221 |
Randomized Phase II Trial of Transoral Endoscopic Head And Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer |
Terminated |
II R |
| 7102 |
Split Course Radiation Therapy of Cancer |
Terminated |
II/III |
| 8531 |
Phase III Study of Zoladex Adjuvant to Radiotherapy in Unfavorable Prognosis Carcinoma of the Prostate |
Terminated |
III |
| 8903 |
A PHASE III TRIAL TO STUDY THE ROLE OF NEOADJUVANT MCV* CHEMOTHERAPY COMBINED WITH TRANSURETHRAL SURGERY PLUS CISPLATIN WITH RADIATION THERAPY FOR SELECTIVE BLADDER PRESERVATION IN PATIENTS WITH MUSCLE-INVADING BLADDER CANCER * MCV: Methotrexate, Cisplatin, Vinblastine |
Terminated |
III |
| 9003 |
A Phase III Randomized Study to Compare Twice Daily Hyperfractionation, Accelerated Hyperfractionation with a Split and Accelerated Fractionation with Concomitant Boost to Standard Fractionation Radiotherapy for Squamous Cell Carcinomas of the Head and Neck |
Terminated |
III |
| 9111 |
Phase III Trial to Preserve the Larynx: Induction Chemotherapy and Radiation Therapy versus Concomitant Chemotherapy and Radiation Therapy versus Radiation Therapy |
Terminated |
III |
| 9202 |
A Phase III Trial of the Use of Long Term Total Androgen Suppression Following Neoadjuvant Hormonal Cytoreduction and Radiotherapy In Locally Advanced Carcinoma of the Prostate |
Terminated |
III |
| 9309 |
A Phase III Comparison between Concurrent Chemotherapy plus Radiotherapy, and Concurrent Chemotherapy plus Radiotherapy Followed by Surgical Resection for Stage IIIA (N2) Non-Small Cell Lung Cancer |
Terminated |
III |
| 9406 |
A Phase I/II Dose Escalation Study Using Three Dimensional Conformal Radiation Therapy for Adenocarcinoma of the Prostate |
Terminated |
I/II |
| 9410 |
A Three-Arm Phase III Study Of Concomitant versus Sequential Chemotherapy and Thoracic Radiotherapy for Patients with Locally Advanced Inoperable Non-Small Cell Lung Cancer |
Terminated |
III |
| 9413 |
A Phase III Trial Comparing Whole Pelvic Irradiation Followed by a Conedown Boost to Boost Irradiation Only and Comparing Neoadjuvant to Adjuvant Total Androgen Suppression (TAS) |
Terminated |
III |
| 9501 |
Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy for Resectable High Risk Squamous Cell Carcinoma of the Head and Neck |
Terminated |
III |
| 9506 |
A Phase I/II Trial Of Transurethral Surgery Plus Induction Chemoradiotherapy Followed Either By Selective Bladder Preservation Or Radical Cystectomy As Determined By Initial Response And Operability In Patients With Muscle-Invading Bladder Cancer |
Terminated |
I/II |
| 9512 |
A Randomized Study of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord |
Terminated |
III |
| 9514 |
A Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall |
Terminated |
II |
| 9517 |
A Phase I/II Trial to Evaluate Brachytherapy as the Sole Method of Radiation Therapy for Stage I and II Breast Carcinoma |
Terminated |
I/II |
| 9609 |
Phase II Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined with Twice Daily Thoracic Radiotherapy for Patients with Limited Stage Small Cell Lung Cancer |
Terminated |
II |
| 9610 |
Phase I/II Study of Concomitant Re-Irradiation, Hydroxyurea and 5-Fluorouracil in Patients with Recurrent Squamous Cell Cancer of the Head and Neck |
Terminated |
I/II |
| 9612 |
Phase II Study of Chemoradiation in Patients with Locally Extensive Epidermoid Carcinoma of the Vulva |
Terminated |
II |
| 9613 |
A Phase II Study of Extended Field Radiation Following Therapeutic Para-Aortic Node Dissection for Patients with Carcinoma of the Uterine Cervix with Para-Aortic Nodal Metastases |
Terminated |
II |
| 9614 |
ECOG E4393: Clinical Efficacy of Molecular Analysis of Surgical Margins and Regional Lymph Nodes in Management of Head and Neck Squamous Cell Carcinoma |
Terminated |
CS |
| 9615 |
Phase II Multi-Institutional Trial of Targeted Supradose Cisplatin Chemoradiation for Stage IV Squamous Cell Carcinoma of the Head and Neck |
Terminated |
II |
| 9701 |
Phase III Randomized Trial of Radiation Therapy Alone versus Concurrent Chemotherapy plus Radiation Therapy for Poor-Risk Stage III Non-Small-Cell Lung Carcinoma |
Terminated |
III |
| 9702 |
CALGB 9343: Evaluation of Lumpectomy, Tamoxifen, and Irradiation of the Breast Compared with Lumpectomy plus Tamoxifen in Women 70 Years of Age or Older Who Have Carcinoma of the Breast That Is Less Than or Equal To 2 cm and Clinically Negative Axillary Nodes: A Phase III Study |
Terminated |
III |
| 9703 |
A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck |
Terminated |
II |
| 9704 |
A Phase III Study of Pre and Post Chemoradiation 5-FU Vs. Pre and Post Chemoradiation Gemcitabine for Postoperative Adjuvant Treatment of Resected Pancreatic Adenocarcinoma |
Terminated |
III |
| 9705 |
Phase II Study of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II and Stage IIIA Non-small Cell Lung Cancer |
Terminated |
II |
| 9706 |
A Phase I/II Trial in Operable Patients with Muscle-Invading Bladder Cancer of Transurethral Surgery and Cisplatinum/ Bid Irradiation Followed either by Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy |
Terminated |
I/II |
| 9707 |
Phase I/II Study of Concomitant Parametrial Boost Radiation Therapy for Locally Advanced Cervical Cancer |
Terminated |
I/II |
| 9708 |
A Phase II Study of Adjuvant Postoperative Irradiation Combined with Cisplatin/Taxol chemotherapy Following TAH/BSO for Patients with High-Risk Endometrial Cancer |
Terminated |
II |
| 9709 |
A Phase III Study to Test the Efficacy of the Prophylactic Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated With Curative Radiation Therapy in Head and Neck Cancer Patients |
Terminated |
III |
| 9710 |
A Phase II Study of Conventional Radiation Therapy Followed with Recombinant Interferon Beta for Supratentorial Glioblastoma |
Terminated |
II |
| 9712 |
A Phase I Dose Escalation Study of Thoracic Irradiation With Concurrent Chemotherapy for Patients With Limited Small Cell Lung Cancer |
Terminated |
I |
| 9713 |
Phase III Randomized Study Comparing Best Supportive Care to Biafine® as a Prophylactic Agent for Radiation-Induced Skin Toxicity for Women Undergoing Breast Irradiation |
Terminated |
III |
| 9714 |
Randomized Trial of Palliative Radiation Therapy For Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life For Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life |
Terminated |
I |
| 9801 |
A Phase III Study of Amifostine Mucosal Protection For Patients With Favorable Prognosis Inoperable Stage II-IIIA/B Non-Small Cell Lung Cancer (NSCLC) Receiving Sequential Induction and Concurrent Hyperfractionated Radiotherapy With Paclitaxel and Carbopl |
Terminated |
III |
| 9803 |
Phase I/II Radiation Dose Escalation Study Applying Conformal Radiation Therapy in Supratentorial Glioblastoma Multiforme |
Terminated |
I/II |
| 9805 |
Phase II Trial of Transrectal Ultrasound Guided Permanent Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate |
Terminated |
II |
| 9806 |
A Phase II Study of Conventional Radiation Therapy Plus Thalidomide for Supratentorial Glioblastoma |
Terminated |
II |
| 9809 |
Phase III Study of Pentosanpolysulfate (PPS) in Treatment of GI Tract Sequelae of Radiotherapy |
Terminated |
III |
| 9811 |
A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Flourouracil, Cisplatin and Radiotherapy in Carcinoma of the Anal Canal |
Terminated |
III |
| 9812 |
A Phase II Trial of External Irradiation (50.4 GY) and Weekly Paclitaxel (Taxol) for Non-Metastatic, Unresectable Pancreatic Cancer |
Terminated |
II |
| 9901 |
A Phase III Study to Test the Efficacy and Safety of GM-CSF to Reduce the Severity and Duration of Mucosal Injury and Pain (Mucositis) Associated With Curative Radiation Therapy in Head and Neck Cancer Patients |
Terminated |
III |
| 9902 |
A Phase III Protocol of Total Androgen Suppression (TAS) and Radiation Therapy (RT) vs TAS and RT Followed by Chemotherapy with Paclitaxel, Estramustine, and Etoposide (TEE) for Localized, High-Risk, Prostate Cancer |
Terminated |
III |
| 9903 |
A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated with Radiotherapy for Carcinoma of the Head and Neck |
Terminated |
III |
| 9904 |
A Phase II Trial of Preoperative Chemotherapy and Chemoradiotherapy For Potentially Resectable Adenocarcinoma of the Stomach |
Terminated |
II |
| 9905 |
A Phase III Study of Adjuvant Postoperative Irradiation With or Without Cisplatin/Paclitaxel Chemotherapy Following TAH/BSO for Patients With Endometrial Cancer |
Terminated |
III |
| 9906 |
A Phase I/II Trial In Patients With Muscle-Invading Bladder Cancer of Transurethral Surgery Plus Taxol, Cisplatin and BID Irradiation Followed by Either Selective Bladder Preservation or Radical Cystectomy and Adjuvant Chemotherapy |
Terminated |
I/II |
| 9909 |
A Phase II Study of Postoperative Adjuvant Immunotherapy and Radiation in Patients with Completely Resected Stage I and Stage IIIA Non-Small Cell Lung Cancer |
Terminated |
II |
| 9911 |
Phase II Study of Paclitaxel and Cisplatin In Combination With Split Course Concomitant Hyperfractionated Re-Irradiation In Patients With Recurrent Squamous Cell Cancer of the Head and Neck |
Terminated |
II |
| 9913 |
A Phase III Comparison of Biafiner to Declared Institutional Preference for Radiation Induced Skin Toxicity In Patients Undergoing Radiation Therapy for Advanced Squamous Cell Carcinomas of the Head and Neck |
Terminated |
III |
| 9914 |
A Phase II Trial of Concomitant Boost Radiation and Concurrent Cisplatin for Advanced Head and Neck Carcinomas |
Terminated |
II |
